Skip to main
ANEB
ANEB logo

Anebulo Pharmaceuticals (ANEB) Market Capitalization Overview

Market Cap: $69.03M as of Jul 3, 2025

$69.03M
Past Month+$25.55M (58.76%)
As of Jul 3, 2025, Anebulo Pharmaceuticals (ANEB) has a market capitalization of $69.03M. Over the past 30 days, its market cap has increased by 65.38%, while in the last 12 months, it has increased by 58.43%.

Market capitalization represents the total value of Anebulo Pharmaceuticals as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Anebulo Pharmaceuticals (ANEB) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Anebulo Pharmaceuticals (ANEB) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Anebulo Pharmaceuticals (ANEB) Market Cap History

DateMarket CapChange
Jul 1, 2025$71.90M+65.38%
Jun 2, 2025$43.48M-10.32%
May 1, 2025$48.48M-0.84%
Apr 1, 2025$48.90M+7.21%
Mar 3, 2025$45.61M-30.63%
Feb 3, 2025$65.74M+60.43%
Jan 2, 2025$40.98M+9.72%

Anebulo Pharmaceuticals (ANEB) End of Year Market Cap History

DateMarket CapChange
2025$69.03M+58.43%
2024$43.57M-29.77%
2023$62.04M-0.15%
2022$62.13M-56.73%
2021$143.57M

FAQs About Anebulo Pharmaceuticals (ANEB) Market Cap

As of Jul 3, 2025, the market capitalization of Anebulo Pharmaceuticals (ANEB) is $69.03M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Anebulo Pharmaceuticals’s market capitalization has increased by 58.76%, changing from $43.48M to $69.03M as of Jul 3, 2025.

In the last 3 months, Anebulo Pharmaceuticals’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Anebulo Pharmaceuticals’s market capitalization decreased from $62.04M in January to $43.57M in December, reflecting a -29.77% change.

In the past five years, Anebulo Pharmaceuticals (ANEB) has had a compound annual growth rate (CAGR) of -25.78% in market capitalization. This means its market cap has shrunk at an average rate of -25.78% per year.

Anebulo Pharmaceuticals (ANEB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.